Multi-omics characterization of improved cognitive functions in parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Multi-omics characterization of improved cognitive functions in parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial | 5 |
Aylık toplam ziyaret
| views | |
|---|---|
| Aralık 2025 | 0 |
| Ocak 2026 | 0 |
| Şubat 2026 | 0 |
| Mart 2026 | 0 |
| Nisan 2026 | 5 |
| Mayıs 2026 | 0 |
| Haziran 2026 | 0 |
Dosya Ziyaretleri
| views | |
|---|---|
| Hanoğlu-Lütfü-2025.pdf | 15 |
